Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 24044795)

1.

Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

van Elmpt W, Das M, Hüllner M, Sharifi H, Zegers CM, Reymen B, Lambin P, Wildberger JE, Troost EG, Veit-Haibach P, De Ruysscher D.

Radiother Oncol. 2013 Oct;109(1):65-70. doi: 10.1016/j.radonc.2013.08.032. Epub 2013 Sep 14.

2.

Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.

Abramyuk A, Wolf G, Shakirin G, Haberland U, Tokalov S, Koch A, Appold S, Zöphel K, Abolmaali N.

Acta Radiol. 2010 Sep;51(7):793-9. doi: 10.3109/02841851.2010.491092.

PMID:
20583948
3.

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.

Sauter AW, Winterstein S, Spira D, Hetzel J, Schulze M, Mueller M, Pfannenberg C, Claussen CD, Klotz E, Hann von Weyhern C, Horger MS.

J Nucl Med. 2012 Apr;53(4):521-9. doi: 10.2967/jnumed.111.097865. Epub 2012 Mar 13.

4.

Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.

Armbruster M, Sourbron S, Haug A, Zech CJ, Ingrisch M, Auernhammer CJ, Nikolaou K, Paprottka PM, Rist C, Reiser MF, Sommer WH.

Invest Radiol. 2014 Jan;49(1):7-14. doi: 10.1097/RLI.0b013e3182a4eb4a.

PMID:
24002080
5.

Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).

Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.

Eur J Radiol. 2013 Nov;82(11):2055-60. doi: 10.1016/j.ejrad.2013.05.027. Epub 2013 Jul 5.

PMID:
23830904
6.

¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.

Champion L, Lerebours F, Cherel P, Edeline V, Giraudet AL, Wartski M, Bellet D, Alberini JL.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1206-13. doi: 10.1007/s00259-013-2405-z. Epub 2013 May 3.

PMID:
23640467
7.

Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma.

Shastry M, Miles KA, Win T, Janes SM, Endozo R, Meagher M, Ell PJ, Groves AM.

Mol Imaging. 2012 Sep-Oct;11(5):353-60.

8.

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.

Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.

Rofo. 2013 Nov;185(11):1056-62. doi: 10.1055/s-0033-1350110. Epub 2013 Jul 16.

9.

Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.

Hwang SH, Yoo MR, Park CH, Jeon TJ, Kim SJ, Kim TH.

Eur Radiol. 2013 Jun;23(6):1573-81. doi: 10.1007/s00330-012-2755-0. Epub 2013 Jan 9.

PMID:
23300040
10.
11.

FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.

Miwa K, Inubushi M, Wagatsuma K, Nagao M, Murata T, Koyama M, Koizumi M, Sasaki M.

Eur J Radiol. 2014 Apr;83(4):715-9. doi: 10.1016/j.ejrad.2013.12.020. Epub 2013 Dec 27.

PMID:
24418285
12.

Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.

Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C.

Acad Radiol. 2012 Jun;19(6):685-92. doi: 10.1016/j.acra.2012.02.013. Epub 2012 Mar 28.

PMID:
22459646
13.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
14.

Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.

Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ.

J Nucl Med. 2008 Jun;49(6):892-8. doi: 10.2967/jnumed.107.049585. Epub 2008 May 15.

15.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
16.

Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.

Soussan M, Cyrta J, Pouliquen C, Chouahnia K, Orlhac F, Martinod E, Eder V, Morère JF, Buvat I.

Radiology. 2014 Sep;272(3):875-84. doi: 10.1148/radiol.14132191. Epub 2014 Apr 23.

PMID:
24761836
17.

Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.

Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.

Clin Nucl Med. 2010 Apr;35(4):237-43. doi: 10.1097/RLU.0b013e3181d18eb0.

PMID:
20305410
18.

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.

Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.

Q J Nucl Med Mol Imaging. 2005 Sep;49(3):259-66.

19.

Variation in background intensity affects PET-based gross tumor volume delineation in non-small-cell lung cancer: the need for individualized information.

Chen GH, Yao ZF, Fan XW, Zhang YJ, Gao HQ, Qian W, Wu KL, Jiang GL.

Radiother Oncol. 2013 Oct;109(1):71-6. doi: 10.1016/j.radonc.2013.08.033. Epub 2013 Sep 20.

PMID:
24060171
20.

Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.

Nahmias C, Hanna WT, Wahl LM, Long MJ, Hubner KF, Townsend DW.

J Nucl Med. 2007 May;48(5):744-51.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk